Comparison between HER2 extracellular domain in serum and HER2 overexpression in breast cancer tissue

被引：0
|
作者：
Zidan, J.
Mzalbat, R.
Shnaider, J.
Sharabi, A.
机构：
[1] Sieff Hosp, Safed, Israel
[2] Ziv Med Ctr, Safed, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e11066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11066
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison between HER2 extracellular domain in serum and HER2 overexpression in breast cancer tissue
    Zidan, J.
    Mzalbat, R.
    Svalb, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S142 - S142
  • [2] SERUM HER2 EXTRACELLULAR DOMAIN LEVELS AND TISSUE HER2 OVEREXPRESSION IN ADVANCED GASTRIC CANCER PATIENTS
    Takahashi, Y.
    Ohori, H.
    Takahashi, M.
    Gamoh, M.
    ANNALS OF ONCOLOGY, 2013, 24 : 32 - 32
  • [3] Correlation between serum HER2 extracellular domain (HER2 ECD) levels and tumour size in early, advanced and metastatic breast cancer with HER2 overexpression
    Makino, H.
    Tengan, H.
    Tatsuda, K.
    Hashidate, H.
    Mio, K.
    Kiguchi, T.
    Yamazaki, M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S114 - S115
  • [4] A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
    Reix, Nathalie
    Malina, Charlotte
    Chenard, Marie-Pierre
    Bellocq, Jean-Pierre
    Delpous, Stephanie
    Moliere, Sebastien
    Sevrin, Anthony
    Neuberger, Karl
    Tomasetto, Catherine
    Mathelin, Carole
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 249 - 259
  • [5] A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
    Nathalie Reix
    Charlotte Malina
    Marie-Pierre Chenard
    Jean-Pierre Bellocq
    Stéphanie Delpous
    Sébastien Molière
    Anthony Sevrin
    Karl Neuberger
    Catherine Tomasetto
    Carole Mathelin
    Breast Cancer Research and Treatment, 2016, 160 : 249 - 259
  • [6] Serum HER2 extracellular domain before surgery compared with HER2 in breast cancer
    Zidan, J.
    Mzalbat, R.
    Sharabi, A.
    BREAST, 2015, 24 : S44 - S45
  • [7] HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
    Tse, Chantal
    Gauchez, Anne-Sophie
    Jacot, William
    Lamy, Pierre-Jean
    CANCER TREATMENT REVIEWS, 2012, 38 (02) : 133 - 142
  • [8] The extracellular domain of Her2 in serum as a biomarker of breast cancer
    Perrier, Alexandre
    Gligorov, Joseph
    Lefevre, Guillaume
    Boissan, Mathieu
    LABORATORY INVESTIGATION, 2018, 98 (06) : 696 - 707
  • [9] Serum HER2 extracellular domain as a potential alternative for tissue HER2 status in metastatic gastric cancer patients
    Peng, Zhi
    Liu, Yi
    Li, Yanyan
    Zhang, Xiaotian
    Zhou, Jun
    Lu, Ming
    Li, Qingqing
    Shen, Lin
    BIOMARKERS IN MEDICINE, 2014, 8 (05) : 663 - 670
  • [10] Relationship between serum HER2 extracellular domain levels, tissue HER2 expression, and clinico-pathological parameters in early stage breast cancer
    Ma Li
    Yang Hong-ying
    Han Xiao-hong
    Li Jia
    Wang Fang
    Zhang Chun-ling
    Yao Jia-rui
    Shi Yuan-kai
    CHINESE MEDICAL JOURNAL, 2012, 125 (22) : 4104 - 4110
12345